StockData
Lifevantage Corp logo

Lifevantage Corp (LFVN) stock

LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3044% below fair value
$4.78+0.01 (+0.21%)

Close on Nov 17, 2026Market cap $59.88MP/E 11.9Yield 3.87%

Lifevantage price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Lifevantage's price to book ratio was 1.8× on Nov 11, 2026, against 2.6× a year earlier. Over the last 5 years it ranged from 1.3× to 9.5×, with a median of 2.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.8×−0.6
2025Dec 31, 20252.4×−5.5
2024Dec 31, 20247.9×+5.3
2023Dec 29, 20232.6×+1.1
2022Dec 30, 20221.5×−0.8
2021Dec 31, 20212.2×−1.6
2020Dec 31, 20203.9×−3.5
2019Dec 31, 20197.4×−0.5
2018Dec 31, 20187.9×+3.6
2017Dec 29, 20174.3×−3.8
2016Dec 30, 20168.1×−20.9
2015Dec 31, 201529.1×+10.9
2014Dec 31, 201418.2×+12.7
2013Dec 31, 20135.5×−1.7
2012Dec 31, 20127.2×–

More Lifevantage figures

See a number that looks wrong?